These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 848909)

  • 41. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
    Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
    J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Frequency of the carrier state for X-linked chronic granulomatous disease among females with lupus erythematosus.
    Humbert JR; Fishman CB; Weston WL; DeArmey PA; Thoren CH
    Clin Genet; 1976 Jul; 10(1):16-20. PubMed ID: 949860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Utilization of liposomes for correction of the metabolic and bactericidal deficiencies in chronic granulomatous disease.
    Ismail G; Boxer LA; Baehner RL
    Pediatr Res; 1979 Jun; 13(6):769-73. PubMed ID: 481946
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity.
    Hand WL; King-Thompson NL
    Antimicrob Agents Chemother; 1986 Jan; 29(1):135-40. PubMed ID: 3790206
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Killing of pathogens associated with chronic granulomatous disease by the non-oxidative microbicidal mechanisms of human neutrophils.
    Odell EW; Segal AW
    J Med Microbiol; 1991 Mar; 34(3):129-35. PubMed ID: 2010902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement of polymorphonuclear leucocyte oxidative and bactericidal functions in chronic granulomatous disease with 4-amino-4'-hydroxylaminodiphenyl sulphone.
    Ismail G; Boxer LA; Allen JM; Baehner RL
    Br J Haematol; 1978 Oct; 40(2):219-29. PubMed ID: 708642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracellular bactericidal activity of leukocytes in whole blood for the diagnosis of chronic granulomatous disease of childhood.
    Keusch GT; Douglas SD; Ugurbil K
    J Infect Dis; 1975 May; 131(5):584-7. PubMed ID: 1092771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The depressing effect of tumour on bactericidal capacity of plasma and leukocytes.
    Merkiel K; Prokopowicz J; Krawczuk J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(4):497-501. PubMed ID: 83269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A case of progressive septic granulomatosis].
    Meilă P; Buşulenga-Nicolau C; Bojinca D; Ursuleanu I; Halunga-Marinescu S
    Rev Pediatr Obstet Ginecol Pediatr; 1975; 24(2):121-6. PubMed ID: 810853
    [No Abstract]   [Full Text] [Related]  

  • 50. [Dysfunction of phagocytosis with special reference to chronic granulomatous disease].
    Usui T; Shimizu B; Amano D
    Nihon Rinsho; 1973 May; 31(5):1051-75. PubMed ID: 4365849
    [No Abstract]   [Full Text] [Related]  

  • 51. Letter: Phagocytosis in chronic granulomatous disease.
    De Gast GC; Ydema WS; Wiersma ME; Dankert J
    Lancet; 1975 May; 1(7918):1247-8. PubMed ID: 48879
    [No Abstract]   [Full Text] [Related]  

  • 52. Adults with chronic granulomatous disease of "childhood".
    Dilworth JA; Mandell GL
    Am J Med; 1977 Aug; 63(2):233-43. PubMed ID: 407791
    [No Abstract]   [Full Text] [Related]  

  • 53. Evaluation of a fluorochrome assay for assessing the bactericidal activity of neutrophils in human phagocyte dysfunctions.
    Bellinati-Pires R; Melki SE; Colletto GM; Carneiro-Sampaio MM
    J Immunol Methods; 1989 May; 119(2):189-96. PubMed ID: 2470824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rifampin in chronic granulomatous disease.
    Lorber B
    N Engl J Med; 1980 Jul; 303(2):111. PubMed ID: 7383064
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of subinhibitory antibiotics on bactericidal activity of chronic granulomatous disease granulocytes in vitro.
    Silva J; Dembinski S; Schaberg D
    J Antimicrob Chemother; 1983 Oct; 12 Suppl C():21-7. PubMed ID: 6643339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phagocytosis in patients and carriers of chronic granulomatous disease.
    Biggar WD
    Lancet; 1975 May; 1(7914):991-5. PubMed ID: 48723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disorders of phagocyte killing and digestion (CGD, G-6-PD and myeloperoxidase deficiencies).
    Czarnetzki BM
    Curr Probl Dermatol; 1989; 18():101-5. PubMed ID: 2545412
    [No Abstract]   [Full Text] [Related]  

  • 58. Enhanced bactericidal activity of phagocytes from patients with chronic granulomatous disease in the presence of sulphisoxazole.
    Johnston RB; Wilfert CM; Buckley RH; Webb LS; DcChatelet LR; McCall CE
    Lancet; 1975 Apr; 1(7911):824-7. PubMed ID: 48055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chronic granulomatous disease involving the larynx and bronchus.
    Frazer JP
    Ann Otol Rhinol Laryngol; 1973; 82(6):816-21. PubMed ID: 4761042
    [No Abstract]   [Full Text] [Related]  

  • 60. The kinetic measurement of phagocyte function in whole blood.
    Boghossian SH; Wright G; Segal AW
    J Immunol Methods; 1983 May; 60(1-2):125-40. PubMed ID: 6854026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.